# 2017-02-01
# Input score file: /home/bzhuang/ND_project_combined/AD_mouse_model_project/mixed_model_jackknife/random_intercept_include_NA_low_exp_rm//jackknife_late_up_regulation_mixed_model_results.tsv
# Input erminej file: /home/bzhuang/ND_project_combined/AD_mouse_model_project/ermineJ/mixed_model_jackknife/random_intercept_include_NA_low_exp_rm_all_processes//2017-02-01_geneset_500/ermineJ_jackknife_late_up_regulation_mixed_model_results.tsv
# only top 174 pathways
# only top 200 genes from the score file are shown ranking in ()
# FDR: corrected p value, []: gene member size of the pathway
geneSymbol	rank	Count	name	sig_paths
Cd68	1	3	lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); endosome- FDR:0.00308[494](GO:0005768)	lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); endosome- FDR:0.00308[494](GO:0005768)
Man2b1	2	14	mannose binding- FDR:0.04272958[10](GO:0005537); trehalase activity- FDR:0.04701795[13](GO:0015927); fucosidase activity- FDR:0.04701795[13](GO:0015928); dextrin alpha-glucosidase activity- FDR:0.04701795[13](GO:0044653); starch alpha-glucosidase activity- FDR:0.04701795[13](GO:0044654); beta-glucanase activity- FDR:0.04701795[13](GO:0052736); beta-6-sulfate-N-acetylglucosaminidase activity- FDR:0.04701795[13](GO:0052769); glucan endo-1,4-beta-glucosidase activity- FDR:0.04701795[13](GO:0052859); galactosidase activity- FDR:0.04904062[15](GO:0015925); hydrolase activity, hydrolyzing O-glycosyl compounds- FDR:0.007032[93](GO:0004553); hydrolase activity, acting on glycosyl bonds- FDR:0.006561[108](GO:0016798); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); carbohydrate metabolic process- FDR:0.001122[327](GO:0005975)	mannose binding- FDR:0.04272958[10](GO:0005537); trehalase activity- FDR:0.04701795[13](GO:0015927); fucosidase activity- FDR:0.04701795[13](GO:0015928); dextrin alpha-glucosidase activity- FDR:0.04701795[13](GO:0044653); starch alpha-glucosidase activity- FDR:0.04701795[13](GO:0044654); beta-glucanase activity- FDR:0.04701795[13](GO:0052736); beta-6-sulfate-N-acetylglucosaminidase activity- FDR:0.04701795[13](GO:0052769); glucan endo-1,4-beta-glucosidase activity- FDR:0.04701795[13](GO:0052859); galactosidase activity- FDR:0.04904062[15](GO:0015925); hydrolase activity, hydrolyzing O-glycosyl compounds- FDR:0.007032[93](GO:0004553); hydrolase activity, acting on glycosyl bonds- FDR:0.006561[108](GO:0016798); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); carbohydrate metabolic process- FDR:0.001122[327](GO:0005975)
Trem2	3	28	cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); response to bacterium- FDR:2.02e-10[154](GO:0009617); leukocyte differentiation- FDR:0.004247[163](GO:0002521); innate immune response- FDR:1.329e-10[173](GO:0045087); cellular response to lipid- FDR:0.01742788[184](GO:0071396); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); response to organonitrogen compound- FDR:0.03124261[301](GO:0010243); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); immune system development- FDR:0.0003812[352](GO:0002520); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); lipid binding- FDR:0.009252[364](GO:0008289); defense response- FDR:2.658e-10[368](GO:0006952); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)	cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); response to bacterium- FDR:2.02e-10[154](GO:0009617); leukocyte differentiation- FDR:0.004247[163](GO:0002521); innate immune response- FDR:1.329e-10[173](GO:0045087); cellular response to lipid- FDR:0.01742788[184](GO:0071396); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); response to organonitrogen compound- FDR:0.03124261[301](GO:0010243); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); immune system development- FDR:0.0003812[352](GO:0002520); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); lipid binding- FDR:0.009252[364](GO:0008289); defense response- FDR:2.658e-10[368](GO:0006952); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)
C1qb	4	18	complement activation, classical pathway- FDR:0.03532441[11](GO:0006958); humoral immune response mediated by circulating immunoglobulin- FDR:0.04175922[12](GO:0002455); complement activation- FDR:0.0469774[14](GO:0006956); immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); activation of immune response- FDR:5.612e-10[87](GO:0002253); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of immune response- FDR:1.263e-10[252](GO:0050776); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); defense response- FDR:2.658e-10[368](GO:0006952); protein homodimerization activity- FDR:0.02137525[476](GO:0042803)	complement activation, classical pathway- FDR:0.03532441[11](GO:0006958); humoral immune response mediated by circulating immunoglobulin- FDR:0.04175922[12](GO:0002455); complement activation- FDR:0.0469774[14](GO:0006956); immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); activation of immune response- FDR:5.612e-10[87](GO:0002253); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of immune response- FDR:1.263e-10[252](GO:0050776); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); defense response- FDR:2.658e-10[368](GO:0006952); protein homodimerization activity- FDR:0.02137525[476](GO:0042803)
Tyrobp	5	10	myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); leukocyte activation- FDR:1.295e-10[227](GO:0045321); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); cell surface- FDR:1.943e-10[384](GO:0009986)	myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); leukocyte activation- FDR:1.295e-10[227](GO:0045321); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); cell surface- FDR:1.943e-10[384](GO:0009986)
C1qa	6	17	complement activation, classical pathway- FDR:0.03532441[11](GO:0006958); humoral immune response mediated by circulating immunoglobulin- FDR:0.04175922[12](GO:0002455); complement activation- FDR:0.0469774[14](GO:0006956); immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); activation of immune response- FDR:5.612e-10[87](GO:0002253); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of immune response- FDR:1.263e-10[252](GO:0050776); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); defense response- FDR:2.658e-10[368](GO:0006952)	complement activation, classical pathway- FDR:0.03532441[11](GO:0006958); humoral immune response mediated by circulating immunoglobulin- FDR:0.04175922[12](GO:0002455); complement activation- FDR:0.0469774[14](GO:0006956); immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); activation of immune response- FDR:5.612e-10[87](GO:0002253); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of immune response- FDR:1.263e-10[252](GO:0050776); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); defense response- FDR:2.658e-10[368](GO:0006952)
Ly86	7	6	positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); inflammatory response- FDR:2.526e-10[151](GO:0006954); innate immune response- FDR:1.329e-10[173](GO:0045087); immune response- FDR:2.405e-10[309](GO:0006955); defense response- FDR:2.658e-10[368](GO:0006952); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101)	positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); inflammatory response- FDR:2.526e-10[151](GO:0006954); innate immune response- FDR:1.329e-10[173](GO:0045087); immune response- FDR:2.405e-10[309](GO:0006955); defense response- FDR:2.658e-10[368](GO:0006952); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101)
Cd14	8	29	regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); response to bacterium- FDR:2.02e-10[154](GO:0009617); innate immune response- FDR:1.329e-10[173](GO:0045087); cellular response to lipid- FDR:0.01742788[184](GO:0071396); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); lipid binding- FDR:0.009252[364](GO:0008289); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201)	regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); response to bacterium- FDR:2.02e-10[154](GO:0009617); innate immune response- FDR:1.329e-10[173](GO:0045087); cellular response to lipid- FDR:0.01742788[184](GO:0071396); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); lipid binding- FDR:0.009252[364](GO:0008289); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201)
Grn	9	5	endocytosis- FDR:2.806e-10[251](GO:0006897); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); cell surface- FDR:1.943e-10[384](GO:0009986); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284)	endocytosis- FDR:2.806e-10[251](GO:0006897); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); cell surface- FDR:1.943e-10[384](GO:0009986); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284)
Ctsz	10	2	lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764)	lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764)
Fcgr3	11	42	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); antigen processing and presentation- FDR:0.005104[47](GO:0019882); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); phagocytosis- FDR:0.004602[53](GO:0006909); regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); leukocyte migration- FDR:0.04148134[70](GO:0050900); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); leukocyte activation- FDR:1.295e-10[227](GO:0045321); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); endocytosis- FDR:2.806e-10[251](GO:0006897); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); defense response- FDR:2.658e-10[368](GO:0006952); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); antigen processing and presentation- FDR:0.005104[47](GO:0019882); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); phagocytosis- FDR:0.004602[53](GO:0006909); regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); leukocyte migration- FDR:0.04148134[70](GO:0050900); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); leukocyte activation- FDR:1.295e-10[227](GO:0045321); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); endocytosis- FDR:2.806e-10[251](GO:0006897); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); defense response- FDR:2.658e-10[368](GO:0006952); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)
Irf8	12	23	defense response to bacterium- FDR:0.009465[50](GO:0042742); phagocytosis- FDR:0.004602[53](GO:0006909); cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); response to bacterium- FDR:2.02e-10[154](GO:0009617); cellular response to lipid- FDR:0.01742788[184](GO:0071396); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); endocytosis- FDR:2.806e-10[251](GO:0006897); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); immune system development- FDR:0.0003812[352](GO:0002520); defense response- FDR:2.658e-10[368](GO:0006952)	defense response to bacterium- FDR:0.009465[50](GO:0042742); phagocytosis- FDR:0.004602[53](GO:0006909); cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); response to bacterium- FDR:2.02e-10[154](GO:0009617); cellular response to lipid- FDR:0.01742788[184](GO:0071396); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); endocytosis- FDR:2.806e-10[251](GO:0006897); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); immune system development- FDR:0.0003812[352](GO:0002520); defense response- FDR:2.658e-10[368](GO:0006952)
C1qc	13	22	complement activation, classical pathway- FDR:0.03532441[11](GO:0006958); humoral immune response mediated by circulating immunoglobulin- FDR:0.04175922[12](GO:0002455); complement activation- FDR:0.0469774[14](GO:0006956); immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); activation of immune response- FDR:5.612e-10[87](GO:0002253); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune response- FDR:1.263e-10[252](GO:0050776); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); defense response- FDR:2.658e-10[368](GO:0006952); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)	complement activation, classical pathway- FDR:0.03532441[11](GO:0006958); humoral immune response mediated by circulating immunoglobulin- FDR:0.04175922[12](GO:0002455); complement activation- FDR:0.0469774[14](GO:0006956); immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); activation of immune response- FDR:5.612e-10[87](GO:0002253); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune response- FDR:1.263e-10[252](GO:0050776); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); defense response- FDR:2.658e-10[368](GO:0006952); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)
Slc11a1	14	58	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); antigen processing and presentation- FDR:0.005104[47](GO:0019882); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); defense response to bacterium- FDR:0.009465[50](GO:0042742); phagocytosis- FDR:0.004602[53](GO:0006909); regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); wound healing- FDR:0.01220322[133](GO:0042060); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); response to wounding- FDR:0.00202[167](GO:0009611); innate immune response- FDR:1.329e-10[173](GO:0045087); lymphocyte activation- FDR:0.007719[182](GO:0046649); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); vacuolar membrane- FDR:0.02154622[229](GO:0005774); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); single organism cell adhesion- FDR:0.001707[249](GO:0098602); endocytosis- FDR:2.806e-10[251](GO:0006897); regulation of immune response- FDR:1.263e-10[252](GO:0050776); vacuolar part- FDR:0.02315042[254](GO:0044437); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); chemical homeostasis- FDR:0.01878224[438](GO:0048878); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); cell adhesion- FDR:2.296e-10[489](GO:0007155); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934); biological adhesion- FDR:0.0005137[493](GO:0022610); endosome- FDR:0.00308[494](GO:0005768)	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); antigen processing and presentation- FDR:0.005104[47](GO:0019882); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); defense response to bacterium- FDR:0.009465[50](GO:0042742); phagocytosis- FDR:0.004602[53](GO:0006909); regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); wound healing- FDR:0.01220322[133](GO:0042060); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); response to wounding- FDR:0.00202[167](GO:0009611); innate immune response- FDR:1.329e-10[173](GO:0045087); lymphocyte activation- FDR:0.007719[182](GO:0046649); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); vacuolar membrane- FDR:0.02154622[229](GO:0005774); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); single organism cell adhesion- FDR:0.001707[249](GO:0098602); endocytosis- FDR:2.806e-10[251](GO:0006897); regulation of immune response- FDR:1.263e-10[252](GO:0050776); vacuolar part- FDR:0.02315042[254](GO:0044437); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); chemical homeostasis- FDR:0.01878224[438](GO:0048878); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); cell adhesion- FDR:2.296e-10[489](GO:0007155); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934); biological adhesion- FDR:0.0005137[493](GO:0022610); endosome- FDR:0.00308[494](GO:0005768)
Gusb	15	5	hydrolase activity, hydrolyzing O-glycosyl compounds- FDR:0.007032[93](GO:0004553); hydrolase activity, acting on glycosyl bonds- FDR:0.006561[108](GO:0016798); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); carbohydrate metabolic process- FDR:0.001122[327](GO:0005975)	hydrolase activity, hydrolyzing O-glycosyl compounds- FDR:0.007032[93](GO:0004553); hydrolase activity, acting on glycosyl bonds- FDR:0.006561[108](GO:0016798); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); carbohydrate metabolic process- FDR:0.001122[327](GO:0005975)
Fcer1g	16.5	76	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); antigen processing and presentation- FDR:0.005104[47](GO:0019882); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); defense response to bacterium- FDR:0.009465[50](GO:0042742); phagocytosis- FDR:0.004602[53](GO:0006909); regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); leukocyte migration- FDR:0.04148134[70](GO:0050900); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); activation of immune response- FDR:5.612e-10[87](GO:0002253); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); defense response to other organism- FDR:1.122e-10[108](GO:0098542); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); response to bacterium- FDR:2.02e-10[154](GO:0009617); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); leukocyte differentiation- FDR:0.004247[163](GO:0002521); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); lymphocyte activation- FDR:0.007719[182](GO:0046649); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); single organism cell adhesion- FDR:0.001707[249](GO:0098602); endocytosis- FDR:2.806e-10[251](GO:0006897); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); antigen processing and presentation- FDR:0.005104[47](GO:0019882); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); defense response to bacterium- FDR:0.009465[50](GO:0042742); phagocytosis- FDR:0.004602[53](GO:0006909); regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); leukocyte migration- FDR:0.04148134[70](GO:0050900); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); activation of immune response- FDR:5.612e-10[87](GO:0002253); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); defense response to other organism- FDR:1.122e-10[108](GO:0098542); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); response to bacterium- FDR:2.02e-10[154](GO:0009617); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); leukocyte differentiation- FDR:0.004247[163](GO:0002521); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); lymphocyte activation- FDR:0.007719[182](GO:0046649); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); single organism cell adhesion- FDR:0.001707[249](GO:0098602); endocytosis- FDR:2.806e-10[251](GO:0006897); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Plek	16.5	19	positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); wound healing- FDR:0.01220322[133](GO:0042060); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); response to wounding- FDR:0.00202[167](GO:0009611); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); lipid binding- FDR:0.009252[364](GO:0008289); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); wound healing- FDR:0.01220322[133](GO:0042060); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); response to wounding- FDR:0.00202[167](GO:0009611); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); lipid binding- FDR:0.009252[364](GO:0008289); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Lgmn	18	5	apical part of cell- FDR:0.009655[206](GO:0045177); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093); endosome- FDR:0.00308[494](GO:0005768)	apical part of cell- FDR:0.009655[206](GO:0045177); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093); endosome- FDR:0.00308[494](GO:0005768)
Gfap	19	3	response to wounding- FDR:0.00202[167](GO:0009611); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)	response to wounding- FDR:0.00202[167](GO:0009611); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)
Gpr84	21	3	transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)	transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)
Slc22a4	22	8	apical plasma membrane- FDR:0.03542176[149](GO:0016324); apical part of cell- FDR:0.009655[206](GO:0045177); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	apical plasma membrane- FDR:0.03542176[149](GO:0016324); apical part of cell- FDR:0.009655[206](GO:0045177); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Sqle	23	5	steroid metabolic process- FDR:0.01882645[108](GO:0008202); alcohol metabolic process- FDR:0.0042[160](GO:0006066); cofactor binding- FDR:0.01756194[184](GO:0048037); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)	steroid metabolic process- FDR:0.01882645[108](GO:0008202); alcohol metabolic process- FDR:0.0042[160](GO:0006066); cofactor binding- FDR:0.01756194[184](GO:0048037); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)
Msmo1	25	12	steroid metabolic process- FDR:0.01882645[108](GO:0008202); alcohol metabolic process- FDR:0.0042[160](GO:0006066); fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	steroid metabolic process- FDR:0.01882645[108](GO:0008202); alcohol metabolic process- FDR:0.0042[160](GO:0006066); fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Hexa	26	8	hydrolase activity, hydrolyzing O-glycosyl compounds- FDR:0.007032[93](GO:0004553); hydrolase activity, acting on glycosyl bonds- FDR:0.006561[108](GO:0016798); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); carbohydrate metabolic process- FDR:0.001122[327](GO:0005975); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135)	hydrolase activity, hydrolyzing O-glycosyl compounds- FDR:0.007032[93](GO:0004553); hydrolase activity, acting on glycosyl bonds- FDR:0.006561[108](GO:0016798); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); carbohydrate metabolic process- FDR:0.001122[327](GO:0005975); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135)
Thy1	27	42	immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); activation of immune response- FDR:5.612e-10[87](GO:0002253); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); apical plasma membrane- FDR:0.03542176[149](GO:0016324); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); apical part of cell- FDR:0.009655[206](GO:0045177); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); regulation of immune response- FDR:1.263e-10[252](GO:0050776); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); cell-cell adhesion- FDR:0.001684[273](GO:0098609); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); lipid binding- FDR:0.009252[364](GO:0008289); regulation of cell migration- FDR:0.0001943[377](GO:0030334); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); activation of immune response- FDR:5.612e-10[87](GO:0002253); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); apical plasma membrane- FDR:0.03542176[149](GO:0016324); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); apical part of cell- FDR:0.009655[206](GO:0045177); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); regulation of immune response- FDR:1.263e-10[252](GO:0050776); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); cell-cell adhesion- FDR:0.001684[273](GO:0098609); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); lipid binding- FDR:0.009252[364](GO:0008289); regulation of cell migration- FDR:0.0001943[377](GO:0030334); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Ctss	28	14	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); antigen processing and presentation- FDR:0.005104[47](GO:0019882); positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); regulation of defense response- FDR:1.742e-10[271](GO:0031347); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); immune response- FDR:2.405e-10[309](GO:0006955); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712)	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); antigen processing and presentation- FDR:0.005104[47](GO:0019882); positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); regulation of defense response- FDR:1.742e-10[271](GO:0031347); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); immune response- FDR:2.405e-10[309](GO:0006955); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712)
Tgfbr2	29	46	myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); leukocyte differentiation- FDR:0.004247[163](GO:0002521); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); leukocyte activation- FDR:1.295e-10[227](GO:0045321); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); endocytosis- FDR:2.806e-10[251](GO:0006897); cell activation- FDR:2.526e-09[276](GO:0001775); response to lipid- FDR:1.629e-10[307](GO:0033993); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); regulation of cell migration- FDR:0.0001943[377](GO:0030334); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); receptor activity- FDR:3.157e-10[473](GO:0004872); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)	myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); leukocyte differentiation- FDR:0.004247[163](GO:0002521); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); leukocyte activation- FDR:1.295e-10[227](GO:0045321); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); endocytosis- FDR:2.806e-10[251](GO:0006897); cell activation- FDR:2.526e-09[276](GO:0001775); response to lipid- FDR:1.629e-10[307](GO:0033993); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); regulation of cell migration- FDR:0.0001943[377](GO:0030334); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); receptor activity- FDR:3.157e-10[473](GO:0004872); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)
Idh1	30	10	cofactor binding- FDR:0.01756194[184](GO:0048037); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); response to lipid- FDR:1.629e-10[307](GO:0033993); carbohydrate metabolic process- FDR:0.001122[327](GO:0005975); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	cofactor binding- FDR:0.01756194[184](GO:0048037); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); response to lipid- FDR:1.629e-10[307](GO:0033993); carbohydrate metabolic process- FDR:0.001122[327](GO:0005975); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Laptm5	31	4	vacuolar membrane- FDR:0.02154622[229](GO:0005774); vacuolar part- FDR:0.02315042[254](GO:0044437); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764)	vacuolar membrane- FDR:0.02154622[229](GO:0005774); vacuolar part- FDR:0.02315042[254](GO:0044437); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764)
Lsp1	32.5	1	defense response- FDR:2.658e-10[368](GO:0006952)	defense response- FDR:2.658e-10[368](GO:0006952)
Slamf9	32.5	1	receptor activity- FDR:3.157e-10[473](GO:0004872)	receptor activity- FDR:3.157e-10[473](GO:0004872)
Slc15a3	35	4	vacuolar membrane- FDR:0.02154622[229](GO:0005774); vacuolar part- FDR:0.02315042[254](GO:0044437); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764)	vacuolar membrane- FDR:0.02154622[229](GO:0005774); vacuolar part- FDR:0.02315042[254](GO:0044437); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764)
Tlr2	36	64	defense response to bacterium- FDR:0.009465[50](GO:0042742); regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); activation of immune response- FDR:5.612e-10[87](GO:0002253); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); response to bacterium- FDR:2.02e-10[154](GO:0009617); innate immune response- FDR:1.329e-10[173](GO:0045087); fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); side of membrane- FDR:1.098e-10[222](GO:0098552); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); leukocyte activation- FDR:1.295e-10[227](GO:0045321); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell activation- FDR:2.526e-09[276](GO:0001775); response to organonitrogen compound- FDR:0.03124261[301](GO:0010243); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); lipid binding- FDR:0.009252[364](GO:0008289); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); receptor activity- FDR:3.157e-10[473](GO:0004872); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533)	defense response to bacterium- FDR:0.009465[50](GO:0042742); regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); activation of immune response- FDR:5.612e-10[87](GO:0002253); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); response to bacterium- FDR:2.02e-10[154](GO:0009617); innate immune response- FDR:1.329e-10[173](GO:0045087); fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); side of membrane- FDR:1.098e-10[222](GO:0098552); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); leukocyte activation- FDR:1.295e-10[227](GO:0045321); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell activation- FDR:2.526e-09[276](GO:0001775); response to organonitrogen compound- FDR:0.03124261[301](GO:0010243); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); lipid binding- FDR:0.009252[364](GO:0008289); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); receptor activity- FDR:3.157e-10[473](GO:0004872); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533)
Tgfbr1	37	26	cytokine receptor binding- FDR:0.04749172[121](GO:0005126); apical plasma membrane- FDR:0.03542176[149](GO:0016324); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); apical part of cell- FDR:0.009655[206](GO:0045177); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); regulation of protein transport- FDR:0.02148454[392](GO:0051223); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); receptor activity- FDR:3.157e-10[473](GO:0004872); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934); endosome- FDR:0.00308[494](GO:0005768)	cytokine receptor binding- FDR:0.04749172[121](GO:0005126); apical plasma membrane- FDR:0.03542176[149](GO:0016324); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); apical part of cell- FDR:0.009655[206](GO:0045177); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); regulation of protein transport- FDR:0.02148454[392](GO:0051223); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); receptor activity- FDR:3.157e-10[473](GO:0004872); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934); endosome- FDR:0.00308[494](GO:0005768)
Lag3	38	24	regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); cell surface- FDR:1.943e-10[384](GO:0009986); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)	regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); cell surface- FDR:1.943e-10[384](GO:0009986); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)
Hexb	39	13	hydrolase activity, hydrolyzing O-glycosyl compounds- FDR:0.007032[93](GO:0004553); hydrolase activity, acting on glycosyl bonds- FDR:0.006561[108](GO:0016798); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); carbohydrate metabolic process- FDR:0.001122[327](GO:0005975); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); chemical homeostasis- FDR:0.01878224[438](GO:0048878); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); protein homodimerization activity- FDR:0.02137525[476](GO:0042803)	hydrolase activity, hydrolyzing O-glycosyl compounds- FDR:0.007032[93](GO:0004553); hydrolase activity, acting on glycosyl bonds- FDR:0.006561[108](GO:0016798); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); carbohydrate metabolic process- FDR:0.001122[327](GO:0005975); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); chemical homeostasis- FDR:0.01878224[438](GO:0048878); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); protein homodimerization activity- FDR:0.02137525[476](GO:0042803)
Siglech	40	3	endocytosis- FDR:2.806e-10[251](GO:0006897); cell surface- FDR:1.943e-10[384](GO:0009986); receptor activity- FDR:3.157e-10[473](GO:0004872)	endocytosis- FDR:2.806e-10[251](GO:0006897); cell surface- FDR:1.943e-10[384](GO:0009986); receptor activity- FDR:3.157e-10[473](GO:0004872)
Anxa3	41	27	defense response to bacterium- FDR:0.009465[50](GO:0042742); phagocytosis- FDR:0.004602[53](GO:0006909); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); leukocyte activation- FDR:1.295e-10[227](GO:0045321); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); endocytosis- FDR:2.806e-10[251](GO:0006897); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); lipid binding- FDR:0.009252[364](GO:0008289); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023)	defense response to bacterium- FDR:0.009465[50](GO:0042742); phagocytosis- FDR:0.004602[53](GO:0006909); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); leukocyte activation- FDR:1.295e-10[227](GO:0045321); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); endocytosis- FDR:2.806e-10[251](GO:0006897); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); lipid binding- FDR:0.009252[364](GO:0008289); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023)
Unc93b1	42	22	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); antigen processing and presentation- FDR:0.005104[47](GO:0019882); immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); activation of immune response- FDR:5.612e-10[87](GO:0002253); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); defense response to other organism- FDR:1.122e-10[108](GO:0098542); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); defense response- FDR:2.658e-10[368](GO:0006952); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); endosome- FDR:0.00308[494](GO:0005768)	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); antigen processing and presentation- FDR:0.005104[47](GO:0019882); immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); activation of immune response- FDR:5.612e-10[87](GO:0002253); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); defense response to other organism- FDR:1.122e-10[108](GO:0098542); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); defense response- FDR:2.658e-10[368](GO:0006952); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); endosome- FDR:0.00308[494](GO:0005768)
Havcr2	43	1	cell surface- FDR:1.943e-10[384](GO:0009986)	cell surface- FDR:1.943e-10[384](GO:0009986)
Ctsa	44	2	lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764)	lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764)
Ctsh	45	30	lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); regulation of immune response- FDR:1.263e-10[252](GO:0050776); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); regulation of cell migration- FDR:0.0001943[377](GO:0030334); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); chemical homeostasis- FDR:0.01878224[438](GO:0048878); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); receptor activity- FDR:3.157e-10[473](GO:0004872)	lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); regulation of immune response- FDR:1.263e-10[252](GO:0050776); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); regulation of cell migration- FDR:0.0001943[377](GO:0030334); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); chemical homeostasis- FDR:0.01878224[438](GO:0048878); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); receptor activity- FDR:3.157e-10[473](GO:0004872)
Ifngr1	46	6	cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); response to cytokine- FDR:1.578e-10[234](GO:0034097); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)	cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); response to cytokine- FDR:1.578e-10[234](GO:0034097); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)
Samsn1	47	6	regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); regulation of immune response- FDR:1.263e-10[252](GO:0050776)	regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); regulation of immune response- FDR:1.263e-10[252](GO:0050776)
Cyba	48	10	apical plasma membrane- FDR:0.03542176[149](GO:0016324); inflammatory response- FDR:2.526e-10[151](GO:0006954); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); innate immune response- FDR:1.329e-10[173](GO:0045087); apical part of cell- FDR:0.009655[206](GO:0045177); immune response- FDR:2.405e-10[309](GO:0006955); defense response- FDR:2.658e-10[368](GO:0006952); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); endosome- FDR:0.00308[494](GO:0005768)	apical plasma membrane- FDR:0.03542176[149](GO:0016324); inflammatory response- FDR:2.526e-10[151](GO:0006954); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); innate immune response- FDR:1.329e-10[173](GO:0045087); apical part of cell- FDR:0.009655[206](GO:0045177); immune response- FDR:2.405e-10[309](GO:0006955); defense response- FDR:2.658e-10[368](GO:0006952); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); endosome- FDR:0.00308[494](GO:0005768)
Nsdhl	49	6	steroid metabolic process- FDR:0.01882645[108](GO:0008202); alcohol metabolic process- FDR:0.0042[160](GO:0006066); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)	steroid metabolic process- FDR:0.01882645[108](GO:0008202); alcohol metabolic process- FDR:0.0042[160](GO:0006066); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)
Ccl6	51	2	cytokine receptor binding- FDR:0.04749172[121](GO:0005126); immune response- FDR:2.405e-10[309](GO:0006955)	cytokine receptor binding- FDR:0.04749172[121](GO:0005126); immune response- FDR:2.405e-10[309](GO:0006955)
Fcgr1	52	46	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); antigen processing and presentation- FDR:0.005104[47](GO:0019882); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); defense response to bacterium- FDR:0.009465[50](GO:0042742); phagocytosis- FDR:0.004602[53](GO:0006909); regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); defense response to other organism- FDR:1.122e-10[108](GO:0098542); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); inflammatory response- FDR:2.526e-10[151](GO:0006954); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); side of membrane- FDR:1.098e-10[222](GO:0098552); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); endocytosis- FDR:2.806e-10[251](GO:0006897); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); antigen processing and presentation- FDR:0.005104[47](GO:0019882); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); defense response to bacterium- FDR:0.009465[50](GO:0042742); phagocytosis- FDR:0.004602[53](GO:0006909); regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); defense response to other organism- FDR:1.122e-10[108](GO:0098542); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); inflammatory response- FDR:2.526e-10[151](GO:0006954); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); side of membrane- FDR:1.098e-10[222](GO:0098552); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); endocytosis- FDR:2.806e-10[251](GO:0006897); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)
Pik3cg	53	34	positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); adaptive immune response- FDR:7.216e-10[70](GO:0002250); leukocyte migration- FDR:0.04148134[70](GO:0050900); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); wound healing- FDR:0.01220322[133](GO:0042060); inflammatory response- FDR:2.526e-10[151](GO:0006954); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); response to wounding- FDR:0.00202[167](GO:0009611); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); endocytosis- FDR:2.806e-10[251](GO:0006897); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); response to organonitrogen compound- FDR:0.03124261[301](GO:0010243); immune response- FDR:2.405e-10[309](GO:0006955); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); defense response- FDR:2.658e-10[368](GO:0006952); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); chemical homeostasis- FDR:0.01878224[438](GO:0048878); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); cell adhesion- FDR:2.296e-10[489](GO:0007155); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934); biological adhesion- FDR:0.0005137[493](GO:0022610)	positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); adaptive immune response- FDR:7.216e-10[70](GO:0002250); leukocyte migration- FDR:0.04148134[70](GO:0050900); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); wound healing- FDR:0.01220322[133](GO:0042060); inflammatory response- FDR:2.526e-10[151](GO:0006954); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); response to wounding- FDR:0.00202[167](GO:0009611); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); endocytosis- FDR:2.806e-10[251](GO:0006897); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); response to organonitrogen compound- FDR:0.03124261[301](GO:0010243); immune response- FDR:2.405e-10[309](GO:0006955); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); defense response- FDR:2.658e-10[368](GO:0006952); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); chemical homeostasis- FDR:0.01878224[438](GO:0048878); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); cell adhesion- FDR:2.296e-10[489](GO:0007155); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934); biological adhesion- FDR:0.0005137[493](GO:0022610)
Abi3	54	4	regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270)	regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270)
Ccl4	55	21	regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); leukocyte migration- FDR:0.04148134[70](GO:0050900); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533)	regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); leukocyte migration- FDR:0.04148134[70](GO:0050900); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533)
Inpp5d	56	31	immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); regulation of immune response- FDR:1.263e-10[252](GO:0050776); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)	immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); regulation of immune response- FDR:1.263e-10[252](GO:0050776); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)
Fcgr2b	57	50	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); antigen processing and presentation- FDR:0.005104[47](GO:0019882); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); phagocytosis- FDR:0.004602[53](GO:0006909); regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); leukocyte activation- FDR:1.295e-10[227](GO:0045321); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); endocytosis- FDR:2.806e-10[251](GO:0006897); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); endosome- FDR:0.00308[494](GO:0005768)	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); immunoglobulin mediated immune response- FDR:0.001243[34](GO:0016064); B cell mediated immunity- FDR:0.001224[35](GO:0019724); antigen processing and presentation- FDR:0.005104[47](GO:0019882); lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); phagocytosis- FDR:0.004602[53](GO:0006909); regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); leukocyte activation- FDR:1.295e-10[227](GO:0045321); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); endocytosis- FDR:2.806e-10[251](GO:0006897); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); endosome- FDR:0.00308[494](GO:0005768)
Selplg	59	9	leukocyte migration- FDR:0.04148134[70](GO:0050900); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	leukocyte migration- FDR:0.04148134[70](GO:0050900); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Osmr	60	9	cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); apical plasma membrane- FDR:0.03542176[149](GO:0016324); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); apical part of cell- FDR:0.009655[206](GO:0045177); response to cytokine- FDR:1.578e-10[234](GO:0034097); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); receptor activity- FDR:3.157e-10[473](GO:0004872)	cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); apical plasma membrane- FDR:0.03542176[149](GO:0016324); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); apical part of cell- FDR:0.009655[206](GO:0045177); response to cytokine- FDR:1.578e-10[234](GO:0034097); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); receptor activity- FDR:3.157e-10[473](GO:0004872)
Nckap1l	61	40	immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); leukocyte migration- FDR:0.04148134[70](GO:0050900); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); activation of immune response- FDR:5.612e-10[87](GO:0002253); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); regulation of immune response- FDR:1.263e-10[252](GO:0050776); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)	immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); leukocyte migration- FDR:0.04148134[70](GO:0050900); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); activation of immune response- FDR:5.612e-10[87](GO:0002253); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); regulation of immune response- FDR:1.263e-10[252](GO:0050776); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)
Tnfsf13b	62	23	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); regulation of immune response- FDR:1.263e-10[252](GO:0050776); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284)	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); regulation of immune response- FDR:1.263e-10[252](GO:0050776); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284)
Tlr7	63	32	myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); activation of immune response- FDR:5.612e-10[87](GO:0002253); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); defense response to other organism- FDR:1.122e-10[108](GO:0098542); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); leukocyte activation- FDR:1.295e-10[227](GO:0045321); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell activation- FDR:2.526e-09[276](GO:0001775); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); defense response- FDR:2.658e-10[368](GO:0006952); regulation of protein transport- FDR:0.02148454[392](GO:0051223); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); receptor activity- FDR:3.157e-10[473](GO:0004872); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); endosome- FDR:0.00308[494](GO:0005768)	myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); activation of immune response- FDR:5.612e-10[87](GO:0002253); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); defense response to other organism- FDR:1.122e-10[108](GO:0098542); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); leukocyte activation- FDR:1.295e-10[227](GO:0045321); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell activation- FDR:2.526e-09[276](GO:0001775); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); defense response- FDR:2.658e-10[368](GO:0006952); regulation of protein transport- FDR:0.02148454[392](GO:0051223); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); receptor activity- FDR:3.157e-10[473](GO:0004872); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); endosome- FDR:0.00308[494](GO:0005768)
Cd9	64	13	external side of plasma membrane- FDR:0.0001981[104](GO:0009897); apical plasma membrane- FDR:0.03542176[149](GO:0016324); apical part of cell- FDR:0.009655[206](GO:0045177); side of membrane- FDR:1.098e-10[222](GO:0098552); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); cell surface- FDR:1.943e-10[384](GO:0009986); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	external side of plasma membrane- FDR:0.0001981[104](GO:0009897); apical plasma membrane- FDR:0.03542176[149](GO:0016324); apical part of cell- FDR:0.009655[206](GO:0045177); side of membrane- FDR:1.098e-10[222](GO:0098552); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); cell surface- FDR:1.943e-10[384](GO:0009986); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Fermt3	65	13	leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); wound healing- FDR:0.01220322[133](GO:0042060); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); response to wounding- FDR:0.00202[167](GO:0009611); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); wound healing- FDR:0.01220322[133](GO:0042060); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); response to wounding- FDR:0.00202[167](GO:0009611); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Cd33	66	5	external side of plasma membrane- FDR:0.0001981[104](GO:0009897); side of membrane- FDR:1.098e-10[222](GO:0098552); cell surface- FDR:1.943e-10[384](GO:0009986); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	external side of plasma membrane- FDR:0.0001981[104](GO:0009897); side of membrane- FDR:1.098e-10[222](GO:0098552); cell surface- FDR:1.943e-10[384](GO:0009986); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Pld4	67	7	phagocytosis- FDR:0.004602[53](GO:0006909); endocytosis- FDR:2.806e-10[251](GO:0006897); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712)	phagocytosis- FDR:0.004602[53](GO:0006909); endocytosis- FDR:2.806e-10[251](GO:0006897); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712)
P2ry6	68	17	apical plasma membrane- FDR:0.03542176[149](GO:0016324); cellular response to lipid- FDR:0.01742788[184](GO:0071396); apical part of cell- FDR:0.009655[206](GO:0045177); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); receptor activity- FDR:3.157e-10[473](GO:0004872)	apical plasma membrane- FDR:0.03542176[149](GO:0016324); cellular response to lipid- FDR:0.01742788[184](GO:0071396); apical part of cell- FDR:0.009655[206](GO:0045177); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); receptor activity- FDR:3.157e-10[473](GO:0004872)
Cd180	69	24	cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); inflammatory response- FDR:2.526e-10[151](GO:0006954); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); lymphocyte activation- FDR:0.007719[182](GO:0046649); cellular response to lipid- FDR:0.01742788[184](GO:0071396); leukocyte activation- FDR:1.295e-10[227](GO:0045321); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); cell activation- FDR:2.526e-09[276](GO:0001775); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); defense response- FDR:2.658e-10[368](GO:0006952); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101)	cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); inflammatory response- FDR:2.526e-10[151](GO:0006954); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); lymphocyte activation- FDR:0.007719[182](GO:0046649); cellular response to lipid- FDR:0.01742788[184](GO:0071396); leukocyte activation- FDR:1.295e-10[227](GO:0045321); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); cell activation- FDR:2.526e-09[276](GO:0001775); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); defense response- FDR:2.658e-10[368](GO:0006952); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101)
Itgb5	70	12	single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); cell-cell adhesion- FDR:0.001684[273](GO:0098609); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); cell surface- FDR:1.943e-10[384](GO:0009986); receptor activity- FDR:3.157e-10[473](GO:0004872); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); cell-cell adhesion- FDR:0.001684[273](GO:0098609); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); cell surface- FDR:1.943e-10[384](GO:0009986); receptor activity- FDR:3.157e-10[473](GO:0004872); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Gpr183	71	29	leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); leukocyte differentiation- FDR:0.004247[163](GO:0002521); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); lymphocyte activation- FDR:0.007719[182](GO:0046649); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); leukocyte activation- FDR:1.295e-10[227](GO:0045321); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); lipid binding- FDR:0.009252[364](GO:0008289); signaling receptor activity- FDR:0.001659[405](GO:0038023); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); receptor activity- FDR:3.157e-10[473](GO:0004872); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)	leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); leukocyte differentiation- FDR:0.004247[163](GO:0002521); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); lymphocyte activation- FDR:0.007719[182](GO:0046649); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); leukocyte activation- FDR:1.295e-10[227](GO:0045321); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); lipid binding- FDR:0.009252[364](GO:0008289); signaling receptor activity- FDR:0.001659[405](GO:0038023); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); receptor activity- FDR:3.157e-10[473](GO:0004872); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)
Tcirg1	72	9	apical plasma membrane- FDR:0.03542176[149](GO:0016324); apical part of cell- FDR:0.009655[206](GO:0045177); vacuolar membrane- FDR:0.02154622[229](GO:0005774); vacuolar part- FDR:0.02315042[254](GO:0044437); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); chemical homeostasis- FDR:0.01878224[438](GO:0048878); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135)	apical plasma membrane- FDR:0.03542176[149](GO:0016324); apical part of cell- FDR:0.009655[206](GO:0045177); vacuolar membrane- FDR:0.02154622[229](GO:0005774); vacuolar part- FDR:0.02315042[254](GO:0044437); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); chemical homeostasis- FDR:0.01878224[438](GO:0048878); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135)
Plce1	73	4	positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)	positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)
Csf3r	75	7	leukocyte migration- FDR:0.04148134[70](GO:0050900); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	leukocyte migration- FDR:0.04148134[70](GO:0050900); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Fyb	76	3	myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); leukocyte activation- FDR:1.295e-10[227](GO:0045321); cell activation- FDR:2.526e-09[276](GO:0001775)	myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); leukocyte activation- FDR:1.295e-10[227](GO:0045321); cell activation- FDR:2.526e-09[276](GO:0001775)
Ptpn6	77	53	lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); activation of immune response- FDR:5.612e-10[87](GO:0002253); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); wound healing- FDR:0.01220322[133](GO:0042060); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); immune effector process- FDR:6.314e-10[167](GO:0002252); response to wounding- FDR:0.00202[167](GO:0009611); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); response to cytokine- FDR:1.578e-10[234](GO:0034097); single organism cell adhesion- FDR:0.001707[249](GO:0098602); regulation of immune response- FDR:1.263e-10[252](GO:0050776); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); defense response- FDR:2.658e-10[368](GO:0006952); signaling receptor activity- FDR:0.001659[405](GO:0038023); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); receptor activity- FDR:3.157e-10[473](GO:0004872); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); activation of immune response- FDR:5.612e-10[87](GO:0002253); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); wound healing- FDR:0.01220322[133](GO:0042060); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); immune effector process- FDR:6.314e-10[167](GO:0002252); response to wounding- FDR:0.00202[167](GO:0009611); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); response to cytokine- FDR:1.578e-10[234](GO:0034097); single organism cell adhesion- FDR:0.001707[249](GO:0098602); regulation of immune response- FDR:1.263e-10[252](GO:0050776); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); defense response- FDR:2.658e-10[368](GO:0006952); signaling receptor activity- FDR:0.001659[405](GO:0038023); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); receptor activity- FDR:3.157e-10[473](GO:0004872); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Ncf4	78	4	vacuolar membrane- FDR:0.02154622[229](GO:0005774); vacuolar part- FDR:0.02315042[254](GO:0044437); lipid binding- FDR:0.009252[364](GO:0008289); endosome- FDR:0.00308[494](GO:0005768)	vacuolar membrane- FDR:0.02154622[229](GO:0005774); vacuolar part- FDR:0.02315042[254](GO:0044437); lipid binding- FDR:0.009252[364](GO:0008289); endosome- FDR:0.00308[494](GO:0005768)
Csf1r	79	37	cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); leukocyte differentiation- FDR:0.004247[163](GO:0002521); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to cytokine- FDR:1.578e-10[234](GO:0034097); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); receptor activity- FDR:3.157e-10[473](GO:0004872); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)	cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); leukocyte differentiation- FDR:0.004247[163](GO:0002521); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to cytokine- FDR:1.578e-10[234](GO:0034097); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); receptor activity- FDR:3.157e-10[473](GO:0004872); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)
Necap2	80	2	endocytosis- FDR:2.806e-10[251](GO:0006897); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023)	endocytosis- FDR:2.806e-10[251](GO:0006897); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023)
Cxcl16	81	28	cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); leukocyte migration- FDR:0.04148134[70](GO:0050900); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); response to bacterium- FDR:2.02e-10[154](GO:0009617); innate immune response- FDR:1.329e-10[173](GO:0045087); cellular response to lipid- FDR:0.01742788[184](GO:0071396); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); endocytosis- FDR:2.806e-10[251](GO:0006897); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); receptor activity- FDR:3.157e-10[473](GO:0004872)	cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); leukocyte migration- FDR:0.04148134[70](GO:0050900); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); response to bacterium- FDR:2.02e-10[154](GO:0009617); innate immune response- FDR:1.329e-10[173](GO:0045087); cellular response to lipid- FDR:0.01742788[184](GO:0071396); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); endocytosis- FDR:2.806e-10[251](GO:0006897); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); receptor activity- FDR:3.157e-10[473](GO:0004872)
Elk3	82	2	wound healing- FDR:0.01220322[133](GO:0042060); response to wounding- FDR:0.00202[167](GO:0009611)	wound healing- FDR:0.01220322[133](GO:0042060); response to wounding- FDR:0.00202[167](GO:0009611)
Hpgd	83	11	fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); cofactor binding- FDR:0.01756194[184](GO:0048037); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); receptor activity- FDR:3.157e-10[473](GO:0004872); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); cofactor binding- FDR:0.01756194[184](GO:0048037); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); receptor activity- FDR:3.157e-10[473](GO:0004872); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Serpina3n	84	6	inflammatory response- FDR:2.526e-10[151](GO:0006954); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to organonitrogen compound- FDR:0.03124261[301](GO:0010243); defense response- FDR:2.658e-10[368](GO:0006952)	inflammatory response- FDR:2.526e-10[151](GO:0006954); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to organonitrogen compound- FDR:0.03124261[301](GO:0010243); defense response- FDR:2.658e-10[368](GO:0006952)
Cd53	85	6	single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell surface- FDR:1.943e-10[384](GO:0009986); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell surface- FDR:1.943e-10[384](GO:0009986); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Gpr34	86	3	transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)	transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)
Slco2b1	87	2	apical plasma membrane- FDR:0.03542176[149](GO:0016324); apical part of cell- FDR:0.009655[206](GO:0045177)	apical plasma membrane- FDR:0.03542176[149](GO:0016324); apical part of cell- FDR:0.009655[206](GO:0045177)
Vkorc1	88	10	wound healing- FDR:0.01220322[133](GO:0042060); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); response to wounding- FDR:0.00202[167](GO:0009611); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); cofactor binding- FDR:0.01756194[184](GO:0048037); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); response to organonitrogen compound- FDR:0.03124261[301](GO:0010243); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)	wound healing- FDR:0.01220322[133](GO:0042060); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); response to wounding- FDR:0.00202[167](GO:0009611); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); cofactor binding- FDR:0.01756194[184](GO:0048037); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); response to organonitrogen compound- FDR:0.03124261[301](GO:0010243); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)
Lcp1	89	22	leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); immune effector process- FDR:6.314e-10[167](GO:0002252); response to wounding- FDR:0.00202[167](GO:0009611); lymphocyte activation- FDR:0.007719[182](GO:0046649); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); immune response- FDR:2.405e-10[309](GO:0006955); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); immune effector process- FDR:6.314e-10[167](GO:0002252); response to wounding- FDR:0.00202[167](GO:0009611); lymphocyte activation- FDR:0.007719[182](GO:0046649); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); immune response- FDR:2.405e-10[309](GO:0006955); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Ggta1	90	2	carbohydrate metabolic process- FDR:0.001122[327](GO:0005975); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135)	carbohydrate metabolic process- FDR:0.001122[327](GO:0005975); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135)
Cd86	91	47	cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); activation of immune response- FDR:5.612e-10[87](GO:0002253); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); response to bacterium- FDR:2.02e-10[154](GO:0009617); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); lymphocyte activation- FDR:0.007719[182](GO:0046649); cellular response to lipid- FDR:0.01742788[184](GO:0071396); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); leukocyte activation- FDR:1.295e-10[227](GO:0045321); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell activation- FDR:2.526e-09[276](GO:0001775); response to lipid- FDR:1.629e-10[307](GO:0033993); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)	cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); activation of immune response- FDR:5.612e-10[87](GO:0002253); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); response to bacterium- FDR:2.02e-10[154](GO:0009617); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); lymphocyte activation- FDR:0.007719[182](GO:0046649); cellular response to lipid- FDR:0.01742788[184](GO:0071396); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); leukocyte activation- FDR:1.295e-10[227](GO:0045321); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell activation- FDR:2.526e-09[276](GO:0001775); response to lipid- FDR:1.629e-10[307](GO:0033993); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)
Arsa	92	9	external side of plasma membrane- FDR:0.0001981[104](GO:0009897); side of membrane- FDR:1.098e-10[222](GO:0098552); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); cell surface- FDR:1.943e-10[384](GO:0009986); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); endosome- FDR:0.00308[494](GO:0005768)	external side of plasma membrane- FDR:0.0001981[104](GO:0009897); side of membrane- FDR:1.098e-10[222](GO:0098552); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); cell surface- FDR:1.943e-10[384](GO:0009986); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); endosome- FDR:0.00308[494](GO:0005768)
Renbp	94	8	regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Ctsc	95	13	lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); positive regulation of cell death- FDR:0.02163691[388](GO:0010942)	lymphocyte mediated immunity- FDR:4.209e-10[50](GO:0002449); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); adaptive immune response- FDR:7.216e-10[70](GO:0002250); immune effector process- FDR:6.314e-10[167](GO:0002252); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); positive regulation of cell death- FDR:0.02163691[388](GO:0010942)
Apbb1ip	96	16	leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); immune effector process- FDR:6.314e-10[167](GO:0002252); lymphocyte activation- FDR:0.007719[182](GO:0046649); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); immune effector process- FDR:6.314e-10[167](GO:0002252); lymphocyte activation- FDR:0.007719[182](GO:0046649); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Eif2ak2	97	24	response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); defense response- FDR:2.658e-10[368](GO:0006952); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)	response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); defense response- FDR:2.658e-10[368](GO:0006952); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)
Il10ra	98	6	cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); response to cytokine- FDR:1.578e-10[234](GO:0034097); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)	cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); response to cytokine- FDR:1.578e-10[234](GO:0034097); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)
Ctsd	99	2	lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764)	lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764)
Fdps	100.5	7	steroid metabolic process- FDR:0.01882645[108](GO:0008202); alcohol metabolic process- FDR:0.0042[160](GO:0006066); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255)	steroid metabolic process- FDR:0.01882645[108](GO:0008202); alcohol metabolic process- FDR:0.0042[160](GO:0006066); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255)
Pros1	102	7	positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); wound healing- FDR:0.01220322[133](GO:0042060); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); response to wounding- FDR:0.00202[167](GO:0009611); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101)	positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); wound healing- FDR:0.01220322[133](GO:0042060); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); response to wounding- FDR:0.00202[167](GO:0009611); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101)
Lgals3bp	104	4	endocytosis- FDR:2.806e-10[251](GO:0006897); receptor activity- FDR:3.157e-10[473](GO:0004872); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	endocytosis- FDR:2.806e-10[251](GO:0006897); receptor activity- FDR:3.157e-10[473](GO:0004872); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Chil1	105	9	hydrolase activity, hydrolyzing O-glycosyl compounds- FDR:0.007032[93](GO:0004553); hydrolase activity, acting on glycosyl bonds- FDR:0.006561[108](GO:0016798); inflammatory response- FDR:2.526e-10[151](GO:0006954); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); carbohydrate metabolic process- FDR:0.001122[327](GO:0005975); defense response- FDR:2.658e-10[368](GO:0006952); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)	hydrolase activity, hydrolyzing O-glycosyl compounds- FDR:0.007032[93](GO:0004553); hydrolase activity, acting on glycosyl bonds- FDR:0.006561[108](GO:0016798); inflammatory response- FDR:2.526e-10[151](GO:0006954); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); carbohydrate metabolic process- FDR:0.001122[327](GO:0005975); defense response- FDR:2.658e-10[368](GO:0006952); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)
Oasl2	106	9	defense response to other organism- FDR:1.122e-10[108](GO:0098542); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); immune response- FDR:2.405e-10[309](GO:0006955); defense response- FDR:2.658e-10[368](GO:0006952); organophosphate metabolic process- FDR:0.004773[433](GO:0019637)	defense response to other organism- FDR:1.122e-10[108](GO:0098542); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); immune response- FDR:2.405e-10[309](GO:0006955); defense response- FDR:2.658e-10[368](GO:0006952); organophosphate metabolic process- FDR:0.004773[433](GO:0019637)
Igf1	107	42	regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); wound healing- FDR:0.01220322[133](GO:0042060); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); response to wounding- FDR:0.00202[167](GO:0009611); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); cell activation- FDR:2.526e-09[276](GO:0001775); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); lipid binding- FDR:0.009252[364](GO:0008289); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); chemical homeostasis- FDR:0.01878224[438](GO:0048878); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)	regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); wound healing- FDR:0.01220322[133](GO:0042060); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); response to wounding- FDR:0.00202[167](GO:0009611); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); cell activation- FDR:2.526e-09[276](GO:0001775); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); lipid binding- FDR:0.009252[364](GO:0008289); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); chemical homeostasis- FDR:0.01878224[438](GO:0048878); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)
Tbxas1	108	10	fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); chemical homeostasis- FDR:0.01878224[438](GO:0048878); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); chemical homeostasis- FDR:0.01878224[438](GO:0048878); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Aldh1l2	111	5	carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Ctsb	112	10	external side of plasma membrane- FDR:0.0001981[104](GO:0009897); apical plasma membrane- FDR:0.03542176[149](GO:0016324); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); apical part of cell- FDR:0.009655[206](GO:0045177); side of membrane- FDR:1.098e-10[222](GO:0098552); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); cell surface- FDR:1.943e-10[384](GO:0009986); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712)	external side of plasma membrane- FDR:0.0001981[104](GO:0009897); apical plasma membrane- FDR:0.03542176[149](GO:0016324); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); apical part of cell- FDR:0.009655[206](GO:0045177); side of membrane- FDR:1.098e-10[222](GO:0098552); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); cell surface- FDR:1.943e-10[384](GO:0009986); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712)
Tgfb1	113	97	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); adaptive immune response- FDR:7.216e-10[70](GO:0002250); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); wound healing- FDR:0.01220322[133](GO:0042060); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); response to bacterium- FDR:2.02e-10[154](GO:0009617); leukocyte differentiation- FDR:0.004247[163](GO:0002521); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); immune effector process- FDR:6.314e-10[167](GO:0002252); response to wounding- FDR:0.00202[167](GO:0009611); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); lymphocyte activation- FDR:0.007719[182](GO:0046649); cellular response to lipid- FDR:0.01742788[184](GO:0071396); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); single organism cell adhesion- FDR:0.001707[249](GO:0098602); regulation of immune response- FDR:1.263e-10[252](GO:0050776); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); immune system development- FDR:0.0003812[352](GO:0002520); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); chemical homeostasis- FDR:0.01878224[438](GO:0048878); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); cell adhesion- FDR:2.296e-10[489](GO:0007155); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934); biological adhesion- FDR:0.0005137[493](GO:0022610)	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); adaptive immune response- FDR:7.216e-10[70](GO:0002250); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); wound healing- FDR:0.01220322[133](GO:0042060); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); response to bacterium- FDR:2.02e-10[154](GO:0009617); leukocyte differentiation- FDR:0.004247[163](GO:0002521); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); immune effector process- FDR:6.314e-10[167](GO:0002252); response to wounding- FDR:0.00202[167](GO:0009611); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); lymphocyte activation- FDR:0.007719[182](GO:0046649); cellular response to lipid- FDR:0.01742788[184](GO:0071396); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); single organism cell adhesion- FDR:0.001707[249](GO:0098602); regulation of immune response- FDR:1.263e-10[252](GO:0050776); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); immune system development- FDR:0.0003812[352](GO:0002520); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); chemical homeostasis- FDR:0.01878224[438](GO:0048878); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); cell adhesion- FDR:2.296e-10[489](GO:0007155); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934); biological adhesion- FDR:0.0005137[493](GO:0022610)
Arpc1b	114	5	focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161)	focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161)
Hcls1	115	13	regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); response to cytokine- FDR:1.578e-10[234](GO:0034097); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)	regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); response to cytokine- FDR:1.578e-10[234](GO:0034097); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)
Lpxn	116.5	10	negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune response- FDR:1.263e-10[252](GO:0050776); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune response- FDR:1.263e-10[252](GO:0050776); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Arhgdib	118	5	regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)	regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)
Naip2	119	15	defense response to bacterium- FDR:0.009465[50](GO:0042742); defense response to other organism- FDR:1.122e-10[108](GO:0098542); inflammatory response- FDR:2.526e-10[151](GO:0006954); response to bacterium- FDR:2.02e-10[154](GO:0009617); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); innate immune response- FDR:1.329e-10[173](GO:0045087); cellular response to lipid- FDR:0.01742788[184](GO:0071396); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); defense response- FDR:2.658e-10[368](GO:0006952)	defense response to bacterium- FDR:0.009465[50](GO:0042742); defense response to other organism- FDR:1.122e-10[108](GO:0098542); inflammatory response- FDR:2.526e-10[151](GO:0006954); response to bacterium- FDR:2.02e-10[154](GO:0009617); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); innate immune response- FDR:1.329e-10[173](GO:0045087); cellular response to lipid- FDR:0.01742788[184](GO:0071396); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); defense response- FDR:2.658e-10[368](GO:0006952)
Hhex	120	9	leukocyte differentiation- FDR:0.004247[163](GO:0002521); lymphocyte activation- FDR:0.007719[182](GO:0046649); leukocyte activation- FDR:1.295e-10[227](GO:0045321); cell activation- FDR:2.526e-09[276](GO:0001775); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)	leukocyte differentiation- FDR:0.004247[163](GO:0002521); lymphocyte activation- FDR:0.007719[182](GO:0046649); leukocyte activation- FDR:1.295e-10[227](GO:0045321); cell activation- FDR:2.526e-09[276](GO:0001775); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)
Gpx1	121	18	regulation of inflammatory response- FDR:0.006964[120](GO:0050727); wound healing- FDR:0.01220322[133](GO:0042060); response to bacterium- FDR:2.02e-10[154](GO:0009617); response to wounding- FDR:0.00202[167](GO:0009611); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533)	regulation of inflammatory response- FDR:0.006964[120](GO:0050727); wound healing- FDR:0.01220322[133](GO:0042060); response to bacterium- FDR:2.02e-10[154](GO:0009617); response to wounding- FDR:0.00202[167](GO:0009611); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533)
Ptgs1	122	12	inflammatory response- FDR:2.526e-10[151](GO:0006954); fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); lipid binding- FDR:0.009252[364](GO:0008289); defense response- FDR:2.658e-10[368](GO:0006952); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	inflammatory response- FDR:2.526e-10[151](GO:0006954); fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); lipid binding- FDR:0.009252[364](GO:0008289); defense response- FDR:2.658e-10[368](GO:0006952); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Ifi30	123	6	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); antigen processing and presentation- FDR:0.005104[47](GO:0019882); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); antigen processing and presentation- FDR:0.005104[47](GO:0019882); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)
Apobec1	124	8	defense response to other organism- FDR:1.122e-10[108](GO:0098542); immune effector process- FDR:6.314e-10[167](GO:0002252); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); defense response- FDR:2.658e-10[368](GO:0006952); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135)	defense response to other organism- FDR:1.122e-10[108](GO:0098542); immune effector process- FDR:6.314e-10[167](GO:0002252); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); defense response- FDR:2.658e-10[368](GO:0006952); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135)
Dhrs1	125	1	oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)	oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)
Cd37	126	14	defense response to other organism- FDR:1.122e-10[108](GO:0098542); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); defense response- FDR:2.658e-10[368](GO:0006952); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101)	defense response to other organism- FDR:1.122e-10[108](GO:0098542); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); defense response- FDR:2.658e-10[368](GO:0006952); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101)
Myo1f	127	26	defense response to bacterium- FDR:0.009465[50](GO:0042742); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); leukocyte activation- FDR:1.295e-10[227](GO:0045321); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270)	defense response to bacterium- FDR:0.009465[50](GO:0042742); myeloid leukocyte activation- FDR:5.051e-10[56](GO:0002274); leukocyte activation involved in immune response- FDR:0.004997[66](GO:0002366); cell activation involved in immune response- FDR:0.005051[67](GO:0002263); leukocyte mediated immunity- FDR:4.592e-10[70](GO:0002443); defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); leukocyte activation- FDR:1.295e-10[227](GO:0045321); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270)
5430435G22Rik	128	15	phagocytosis- FDR:0.004602[53](GO:0006909); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); vacuolar membrane- FDR:0.02154622[229](GO:0005774); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); endocytosis- FDR:2.806e-10[251](GO:0006897); regulation of immune response- FDR:1.263e-10[252](GO:0050776); vacuolar part- FDR:0.02315042[254](GO:0044437); regulation of defense response- FDR:1.742e-10[271](GO:0031347); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); endosome- FDR:0.00308[494](GO:0005768)	phagocytosis- FDR:0.004602[53](GO:0006909); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); vacuolar membrane- FDR:0.02154622[229](GO:0005774); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); endocytosis- FDR:2.806e-10[251](GO:0006897); regulation of immune response- FDR:1.263e-10[252](GO:0050776); vacuolar part- FDR:0.02315042[254](GO:0044437); regulation of defense response- FDR:1.742e-10[271](GO:0031347); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); endosome- FDR:0.00308[494](GO:0005768)
Skap2	129	4	lymphocyte activation- FDR:0.007719[182](GO:0046649); leukocyte activation- FDR:1.295e-10[227](GO:0045321); cell activation- FDR:2.526e-09[276](GO:0001775); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285)	lymphocyte activation- FDR:0.007719[182](GO:0046649); leukocyte activation- FDR:1.295e-10[227](GO:0045321); cell activation- FDR:2.526e-09[276](GO:0001775); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285)
Rac2	130	27	positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); single organism cell adhesion- FDR:0.001707[249](GO:0098602); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); cell-cell adhesion- FDR:0.001684[273](GO:0098609); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); single organism cell adhesion- FDR:0.001707[249](GO:0098602); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); cell-cell adhesion- FDR:0.001684[273](GO:0098609); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Axl	131	55	phagocytosis- FDR:0.004602[53](GO:0006909); regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); wound healing- FDR:0.01220322[133](GO:0042060); inflammatory response- FDR:2.526e-10[151](GO:0006954); response to bacterium- FDR:2.02e-10[154](GO:0009617); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); leukocyte differentiation- FDR:0.004247[163](GO:0002521); response to wounding- FDR:0.00202[167](GO:0009611); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); lymphocyte activation- FDR:0.007719[182](GO:0046649); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); cellular response to lipid- FDR:0.01742788[184](GO:0071396); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); leukocyte activation- FDR:1.295e-10[227](GO:0045321); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); single organism cell adhesion- FDR:0.001707[249](GO:0098602); endocytosis- FDR:2.806e-10[251](GO:0006897); cell activation- FDR:2.526e-09[276](GO:0001775); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); immune system development- FDR:0.0003812[352](GO:0002520); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); lipid binding- FDR:0.009252[364](GO:0008289); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	phagocytosis- FDR:0.004602[53](GO:0006909); regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); positive regulation of endocytosis- FDR:0.01087249[71](GO:0045807); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); regulation of endocytosis- FDR:0.02487703[126](GO:0030100); wound healing- FDR:0.01220322[133](GO:0042060); inflammatory response- FDR:2.526e-10[151](GO:0006954); response to bacterium- FDR:2.02e-10[154](GO:0009617); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); leukocyte differentiation- FDR:0.004247[163](GO:0002521); response to wounding- FDR:0.00202[167](GO:0009611); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); lymphocyte activation- FDR:0.007719[182](GO:0046649); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); cellular response to lipid- FDR:0.01742788[184](GO:0071396); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); leukocyte activation- FDR:1.295e-10[227](GO:0045321); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); single organism cell adhesion- FDR:0.001707[249](GO:0098602); endocytosis- FDR:2.806e-10[251](GO:0006897); cell activation- FDR:2.526e-09[276](GO:0001775); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); immune system development- FDR:0.0003812[352](GO:0002520); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); lipid binding- FDR:0.009252[364](GO:0008289); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Slc29a3	132	5	vacuolar membrane- FDR:0.02154622[229](GO:0005774); vacuolar part- FDR:0.02315042[254](GO:0044437); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); endosome- FDR:0.00308[494](GO:0005768)	vacuolar membrane- FDR:0.02154622[229](GO:0005774); vacuolar part- FDR:0.02315042[254](GO:0044437); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); endosome- FDR:0.00308[494](GO:0005768)
Plod3	133	1	oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)	oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)
Lpcat2	134	6	alcohol metabolic process- FDR:0.0042[160](GO:0006066); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255)	alcohol metabolic process- FDR:0.0042[160](GO:0006066); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255)
Oat	135	1	cofactor binding- FDR:0.01756194[184](GO:0048037)	cofactor binding- FDR:0.01756194[184](GO:0048037)
Psme1	138	3	antigen processing and presentation- FDR:0.005104[47](GO:0019882); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547)	antigen processing and presentation- FDR:0.005104[47](GO:0019882); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547)
Dock8	139.5	11	leukocyte migration- FDR:0.04148134[70](GO:0050900); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); lymphocyte activation- FDR:0.007719[182](GO:0046649); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	leukocyte migration- FDR:0.04148134[70](GO:0050900); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); lymphocyte activation- FDR:0.007719[182](GO:0046649); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Nfe2l2	139.5	7	positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); response to cytokine- FDR:1.578e-10[234](GO:0034097); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101)	positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); response to cytokine- FDR:1.578e-10[234](GO:0034097); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101)
Il13ra1	141	6	cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); response to cytokine- FDR:1.578e-10[234](GO:0034097); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)	cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); response to cytokine- FDR:1.578e-10[234](GO:0034097); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)
Msn	142	14	apical plasma membrane- FDR:0.03542176[149](GO:0016324); apical part of cell- FDR:0.009655[206](GO:0045177); side of membrane- FDR:1.098e-10[222](GO:0098552); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); regulation of cell migration- FDR:0.0001943[377](GO:0030334); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023)	apical plasma membrane- FDR:0.03542176[149](GO:0016324); apical part of cell- FDR:0.009655[206](GO:0045177); side of membrane- FDR:1.098e-10[222](GO:0098552); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); regulation of cell migration- FDR:0.0001943[377](GO:0030334); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023)
Klhl6	143	9	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); adaptive immune response- FDR:7.216e-10[70](GO:0002250); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); activation of immune response- FDR:5.612e-10[87](GO:0002253); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); regulation of immune response- FDR:1.263e-10[252](GO:0050776); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684)	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:3.885e-10[59](GO:0002460); immune response-activating signal transduction- FDR:0.01096542[69](GO:0002757); adaptive immune response- FDR:7.216e-10[70](GO:0002250); immune response-regulating signaling pathway- FDR:0.0006735[78](GO:0002764); activation of immune response- FDR:5.612e-10[87](GO:0002253); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); regulation of immune response- FDR:1.263e-10[252](GO:0050776); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684)
Irf5	144	17	defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); response to organonitrogen compound- FDR:0.03124261[301](GO:0010243); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); defense response- FDR:2.658e-10[368](GO:0006952); positive regulation of cell death- FDR:0.02163691[388](GO:0010942)	defense response to other organism- FDR:1.122e-10[108](GO:0098542); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); response to bacterium- FDR:2.02e-10[154](GO:0009617); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); response to organonitrogen compound- FDR:0.03124261[301](GO:0010243); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); defense response- FDR:2.658e-10[368](GO:0006952); positive regulation of cell death- FDR:0.02163691[388](GO:0010942)
Spp1	145.5	8	leukocyte migration- FDR:0.04148134[70](GO:0050900); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); apical part of cell- FDR:0.009655[206](GO:0045177); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	leukocyte migration- FDR:0.04148134[70](GO:0050900); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); apical part of cell- FDR:0.009655[206](GO:0045177); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Tnfrsf1a	145.5	42	defense response to bacterium- FDR:0.009465[50](GO:0042742); regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); defense response to other organism- FDR:1.122e-10[108](GO:0098542); cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); response to bacterium- FDR:2.02e-10[154](GO:0009617); fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); regulation of defense response- FDR:1.742e-10[271](GO:0031347); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); regulation of protein transport- FDR:0.02148454[392](GO:0051223); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); receptor activity- FDR:3.157e-10[473](GO:0004872); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)	defense response to bacterium- FDR:0.009465[50](GO:0042742); regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); defense response to other organism- FDR:1.122e-10[108](GO:0098542); cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); inflammatory response- FDR:2.526e-10[151](GO:0006954); response to bacterium- FDR:2.02e-10[154](GO:0009617); fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); regulation of defense response- FDR:1.742e-10[271](GO:0031347); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); regulation of protein transport- FDR:0.02148454[392](GO:0051223); signaling receptor activity- FDR:0.001659[405](GO:0038023); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); receptor activity- FDR:3.157e-10[473](GO:0004872); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)
B2m	147	38	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); antigen processing and presentation- FDR:0.005104[47](GO:0019882); regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); response to bacterium- FDR:2.02e-10[154](GO:0009617); leukocyte differentiation- FDR:0.004247[163](GO:0002521); lymphocyte activation- FDR:0.007719[182](GO:0046649); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); side of membrane- FDR:1.098e-10[222](GO:0098552); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); single organism cell adhesion- FDR:0.001707[249](GO:0098602); regulation of immune response- FDR:1.263e-10[252](GO:0050776); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); chemical homeostasis- FDR:0.01878224[438](GO:0048878); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	antigen processing and presentation of peptide antigen- FDR:0.005156[26](GO:0048002); antigen processing and presentation- FDR:0.005104[47](GO:0019882); regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); response to bacterium- FDR:2.02e-10[154](GO:0009617); leukocyte differentiation- FDR:0.004247[163](GO:0002521); lymphocyte activation- FDR:0.007719[182](GO:0046649); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); side of membrane- FDR:1.098e-10[222](GO:0098552); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); single organism cell adhesion- FDR:0.001707[249](GO:0098602); regulation of immune response- FDR:1.263e-10[252](GO:0050776); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); chemical homeostasis- FDR:0.01878224[438](GO:0048878); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Syngr2	148	1	cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023)	cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023)
Hrsp12	149	3	negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); lipid binding- FDR:0.009252[364](GO:0008289); protein homodimerization activity- FDR:0.02137525[476](GO:0042803)	negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); lipid binding- FDR:0.009252[364](GO:0008289); protein homodimerization activity- FDR:0.02137525[476](GO:0042803)
Tmem176b	151	4	regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)	regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)
Cd83	152	22	negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); cell surface- FDR:1.943e-10[384](GO:0009986)	negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); positive regulation of lymphocyte activation- FDR:0.01854546[104](GO:0051251); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); positive regulation of leukocyte activation- FDR:0.007101[116](GO:0002696); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of cell activation- FDR:0.001911[123](GO:0050867); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); cell surface- FDR:1.943e-10[384](GO:0009986)
S100a6	153	2	side of membrane- FDR:1.098e-10[222](GO:0098552); protein homodimerization activity- FDR:0.02137525[476](GO:0042803)	side of membrane- FDR:1.098e-10[222](GO:0098552); protein homodimerization activity- FDR:0.02137525[476](GO:0042803)
Trf	154	20	apical plasma membrane- FDR:0.03542176[149](GO:0016324); leukocyte differentiation- FDR:0.004247[163](GO:0002521); apical part of cell- FDR:0.009655[206](GO:0045177); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); chemical homeostasis- FDR:0.01878224[438](GO:0048878); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934); endosome- FDR:0.00308[494](GO:0005768)	apical plasma membrane- FDR:0.03542176[149](GO:0016324); leukocyte differentiation- FDR:0.004247[163](GO:0002521); apical part of cell- FDR:0.009655[206](GO:0045177); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); chemical homeostasis- FDR:0.01878224[438](GO:0048878); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934); endosome- FDR:0.00308[494](GO:0005768)
Gpnmb	156	3	cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Acaca	157	13	fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); cellular response to lipid- FDR:0.01742788[184](GO:0071396); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); chemical homeostasis- FDR:0.01878224[438](GO:0048878); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); cellular response to lipid- FDR:0.01742788[184](GO:0071396); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); chemical homeostasis- FDR:0.01878224[438](GO:0048878); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Ccl12	159	34	cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); leukocyte migration- FDR:0.04148134[70](GO:0050900); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); inflammatory response- FDR:2.526e-10[151](GO:0006954); response to bacterium- FDR:2.02e-10[154](GO:0009617); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); cellular response to lipid- FDR:0.01742788[184](GO:0071396); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270)	cellular response to lipopolysaccharide- FDR:0.009268[60](GO:0071222); cellular response to molecule of bacterial origin- FDR:0.002127[66](GO:0071219); leukocyte migration- FDR:0.04148134[70](GO:0050900); cellular response to biotic stimulus- FDR:0.003948[79](GO:0071216); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); response to lipopolysaccharide- FDR:0.0009776[99](GO:0032496); response to molecule of bacterial origin- FDR:8.418e-10[110](GO:0002237); cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); inflammatory response- FDR:2.526e-10[151](GO:0006954); response to bacterium- FDR:2.02e-10[154](GO:0009617); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); cellular response to lipid- FDR:0.01742788[184](GO:0071396); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); response to lipid- FDR:1.629e-10[307](GO:0033993); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270)
Alox5ap	160	20	positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); inflammatory response- FDR:2.526e-10[151](GO:0006954); fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); regulation of defense response- FDR:1.742e-10[271](GO:0031347); lipid binding- FDR:0.009252[364](GO:0008289); defense response- FDR:2.658e-10[368](GO:0006952); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	positive regulation of response to wounding- FDR:0.01148695[66](GO:1903036); positive regulation of defense response- FDR:0.0009936[94](GO:0031349); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); inflammatory response- FDR:2.526e-10[151](GO:0006954); fatty acid metabolic process- FDR:0.04149492[173](GO:0006631); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); regulation of defense response- FDR:1.742e-10[271](GO:0031347); lipid binding- FDR:0.009252[364](GO:0008289); defense response- FDR:2.658e-10[368](GO:0006952); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Padi2	161	13	cellular response to lipid- FDR:0.01742788[184](GO:0071396); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	cellular response to lipid- FDR:0.01742788[184](GO:0071396); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Ifitm3	162	20	defense response to other organism- FDR:1.122e-10[108](GO:0098542); cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); apical part of cell- FDR:0.009655[206](GO:0045177); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); endocytosis- FDR:2.806e-10[251](GO:0006897); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); immune response- FDR:2.405e-10[309](GO:0006955); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); endosome- FDR:0.00308[494](GO:0005768)	defense response to other organism- FDR:1.122e-10[108](GO:0098542); cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); apical part of cell- FDR:0.009655[206](GO:0045177); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); endocytosis- FDR:2.806e-10[251](GO:0006897); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); immune response- FDR:2.405e-10[309](GO:0006955); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); defense response- FDR:2.658e-10[368](GO:0006952); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023); endosome- FDR:0.00308[494](GO:0005768)
Glipr2	163	12	positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)	positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); positive regulation of MAPK cascade- FDR:0.006869[256](GO:0043410); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)
Cyb5r3	166	7	steroid metabolic process- FDR:0.01882645[108](GO:0008202); alcohol metabolic process- FDR:0.0042[160](GO:0006066); cofactor binding- FDR:0.01756194[184](GO:0048037); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)	steroid metabolic process- FDR:0.01882645[108](GO:0008202); alcohol metabolic process- FDR:0.0042[160](GO:0006066); cofactor binding- FDR:0.01756194[184](GO:0048037); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); small molecule biosynthetic process- FDR:0.003848[224](GO:0044283); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)
Tnfaip8l2	167	16	regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); regulation of defense response- FDR:1.742e-10[271](GO:0031347); immune response- FDR:2.405e-10[309](GO:0006955); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); defense response- FDR:2.658e-10[368](GO:0006952); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101)	regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); regulation of inflammatory response- FDR:0.006964[120](GO:0050727); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); regulation of defense response- FDR:1.742e-10[271](GO:0031347); immune response- FDR:2.405e-10[309](GO:0006955); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); defense response- FDR:2.658e-10[368](GO:0006952); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101)
Stat3	168	18	cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); inflammatory response- FDR:2.526e-10[151](GO:0006954); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to organonitrogen compound- FDR:0.03124261[301](GO:0010243); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); chemical homeostasis- FDR:0.01878224[438](GO:0048878); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)	cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); inflammatory response- FDR:2.526e-10[151](GO:0006954); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); response to cytokine- FDR:1.578e-10[234](GO:0034097); response to organonitrogen compound- FDR:0.03124261[301](GO:0010243); response to lipid- FDR:1.629e-10[307](GO:0033993); response to organic cyclic compound- FDR:0.001105[332](GO:0014070); cellular response to oxygen-containing compound- FDR:0.0003483[350](GO:1901701); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); chemical homeostasis- FDR:0.01878224[438](GO:0048878); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)
Npc2	170	7	steroid metabolic process- FDR:0.01882645[108](GO:0008202); alcohol metabolic process- FDR:0.0042[160](GO:0006066); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); lipid binding- FDR:0.009252[364](GO:0008289); chemical homeostasis- FDR:0.01878224[438](GO:0048878)	steroid metabolic process- FDR:0.01882645[108](GO:0008202); alcohol metabolic process- FDR:0.0042[160](GO:0006066); organic hydroxy compound metabolic process- FDR:0.003803[218](GO:1901615); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); lipid binding- FDR:0.009252[364](GO:0008289); chemical homeostasis- FDR:0.01878224[438](GO:0048878)
Lmo2	171	7	regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); cofactor binding- FDR:0.01756194[184](GO:0048037); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)	regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); cofactor binding- FDR:0.01756194[184](GO:0048037); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)
Lyz1	172	10	defense response to bacterium- FDR:0.009465[50](GO:0042742); hydrolase activity, hydrolyzing O-glycosyl compounds- FDR:0.007032[93](GO:0004553); defense response to other organism- FDR:1.122e-10[108](GO:0098542); hydrolase activity, acting on glycosyl bonds- FDR:0.006561[108](GO:0016798); response to bacterium- FDR:2.02e-10[154](GO:0009617); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); defense response- FDR:2.658e-10[368](GO:0006952); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023)	defense response to bacterium- FDR:0.009465[50](GO:0042742); hydrolase activity, hydrolyzing O-glycosyl compounds- FDR:0.007032[93](GO:0004553); defense response to other organism- FDR:1.122e-10[108](GO:0098542); hydrolase activity, acting on glycosyl bonds- FDR:0.006561[108](GO:0016798); response to bacterium- FDR:2.02e-10[154](GO:0009617); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); defense response- FDR:2.658e-10[368](GO:0006952); cytoplasmic, membrane-bounded vesicle- FDR:0.02153127[457](GO:0016023)
Adgre1	174	6	external side of plasma membrane- FDR:0.0001981[104](GO:0009897); side of membrane- FDR:1.098e-10[222](GO:0098552); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); cell surface- FDR:1.943e-10[384](GO:0009986); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)	external side of plasma membrane- FDR:0.0001981[104](GO:0009897); side of membrane- FDR:1.098e-10[222](GO:0098552); transmembrane signaling receptor activity- FDR:0.000202[359](GO:0004888); cell surface- FDR:1.943e-10[384](GO:0009986); signaling receptor activity- FDR:0.001659[405](GO:0038023); receptor activity- FDR:3.157e-10[473](GO:0004872)
Casp8	175	17	cytokine receptor binding- FDR:0.04749172[121](GO:0005126); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); leukocyte differentiation- FDR:0.004247[163](GO:0002521); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); response to cytokine- FDR:1.578e-10[234](GO:0034097); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533)	cytokine receptor binding- FDR:0.04749172[121](GO:0005126); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); leukocyte differentiation- FDR:0.004247[163](GO:0002521); regulation of endopeptidase activity- FDR:0.04123395[172](GO:0052548); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); membrane raft- FDR:0.01133395[186](GO:0045121); membrane microdomain- FDR:0.01133395[186](GO:0098857); regulation of peptidase activity- FDR:0.03176813[198](GO:0052547); response to cytokine- FDR:1.578e-10[234](GO:0034097); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533)
Slc44a2	176	5	vacuolar membrane- FDR:0.02154622[229](GO:0005774); vacuolar part- FDR:0.02315042[254](GO:0044437); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533)	vacuolar membrane- FDR:0.02154622[229](GO:0005774); vacuolar part- FDR:0.02315042[254](GO:0044437); lytic vacuole- FDR:5.051e-09[295](GO:0000323); lysosome- FDR:5.051e-09[295](GO:0005764); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533)
Vim	177	11	focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)	focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)
Anxa5	178	23	external side of plasma membrane- FDR:0.0001981[104](GO:0009897); wound healing- FDR:0.01220322[133](GO:0042060); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); response to wounding- FDR:0.00202[167](GO:0009611); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); side of membrane- FDR:1.098e-10[222](GO:0098552); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); regulation of defense response- FDR:1.742e-10[271](GO:0031347); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); lipid binding- FDR:0.009252[364](GO:0008289); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712)	external side of plasma membrane- FDR:0.0001981[104](GO:0009897); wound healing- FDR:0.01220322[133](GO:0042060); regulation of body fluid levels- FDR:0.02382679[162](GO:0050878); response to wounding- FDR:0.00202[167](GO:0009611); regulation of response to wounding- FDR:1.052e-10[183](GO:1903034); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); side of membrane- FDR:1.098e-10[222](GO:0098552); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); regulation of defense response- FDR:1.742e-10[271](GO:0031347); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); lipid binding- FDR:0.009252[364](GO:0008289); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); cell surface- FDR:1.943e-10[384](GO:0009986); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712)
St6gal1	179	5	carbohydrate metabolic process- FDR:0.001122[327](GO:0005975); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	carbohydrate metabolic process- FDR:0.001122[327](GO:0005975); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Sla	180	1	endosome- FDR:0.00308[494](GO:0005768)	endosome- FDR:0.00308[494](GO:0005768)
Cmtm3	181	2	regulation of immune response- FDR:1.263e-10[252](GO:0050776); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684)	regulation of immune response- FDR:1.263e-10[252](GO:0050776); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684)
Abcb1b	182	2	apical plasma membrane- FDR:0.03542176[149](GO:0016324); apical part of cell- FDR:0.009655[206](GO:0045177)	apical plasma membrane- FDR:0.03542176[149](GO:0016324); apical part of cell- FDR:0.009655[206](GO:0045177)
4632428N05Rik	183	23	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); cell surface- FDR:1.943e-10[384](GO:0009986)	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); regulation of lymphocyte proliferation- FDR:0.03233952[95](GO:0050670); regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); external side of plasma membrane- FDR:0.0001981[104](GO:0009897); regulation of T cell activation- FDR:0.01081091[112](GO:0050863); regulation of leukocyte cell-cell adhesion- FDR:0.01110385[115](GO:1903037); regulation of homotypic cell-cell adhesion- FDR:0.01129047[124](GO:0034110); regulation of cell-cell adhesion- FDR:0.0107169[164](GO:0022407); regulation of lymphocyte activation- FDR:1.175e-10[171](GO:0051249); negative regulation of immune system process- FDR:0.0003741[189](GO:0002683); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of leukocyte activation- FDR:3.367e-10[199](GO:0002694); regulation of cell activation- FDR:1.203e-10[220](GO:0050865); side of membrane- FDR:1.098e-10[222](GO:0098552); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); cell surface- FDR:1.943e-10[384](GO:0009986)
Stat2	184	4	regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of defense response- FDR:1.742e-10[271](GO:0031347); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712)	regulation of immune effector process- FDR:0.01142685[192](GO:0002697); regulation of defense response- FDR:1.742e-10[271](GO:0031347); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712)
As3mt	185	4	monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Aspg	186	6	organophosphate metabolic process- FDR:0.004773[433](GO:0019637); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	organophosphate metabolic process- FDR:0.004773[433](GO:0019637); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); cellular lipid metabolic process- FDR:1.403e-10[450](GO:0044255); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Adssl1	187	6	organophosphate metabolic process- FDR:0.004773[433](GO:0019637); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	organophosphate metabolic process- FDR:0.004773[433](GO:0019637); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Pmp22	188	2	negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)	negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)
Hk2	190	9	monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); carbohydrate metabolic process- FDR:0.001122[327](GO:0005975); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); chemical homeostasis- FDR:0.01878224[438](GO:0048878); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)	monocarboxylic acid metabolic process- FDR:0.001732[249](GO:0032787); carbohydrate metabolic process- FDR:0.001122[327](GO:0005975); organophosphate metabolic process- FDR:0.004773[433](GO:0019637); carboxylic acid metabolic process- FDR:1.804e-10[434](GO:0019752); chemical homeostasis- FDR:0.01878224[438](GO:0048878); single-organism catabolic process- FDR:1.365e-10[458](GO:0044712); oxoacid metabolic process- FDR:1.443e-10[474](GO:0043436); carbohydrate derivative metabolic process- FDR:0.02106989[476](GO:1901135); organic acid metabolic process- FDR:2.971e-10[480](GO:0006082)
Tspo	192	15	regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); steroid metabolic process- FDR:0.01882645[108](GO:0008202); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); lipid binding- FDR:0.009252[364](GO:0008289); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); signaling receptor activity- FDR:0.001659[405](GO:0038023); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); receptor activity- FDR:3.157e-10[473](GO:0004872); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)	regulation of tumor necrosis factor production- FDR:0.01387021[55](GO:0032680); regulation of tumor necrosis factor superfamily cytokine production- FDR:0.009184[57](GO:1903555); negative regulation of cytokine production- FDR:0.01773816[93](GO:0001818); steroid metabolic process- FDR:0.01882645[108](GO:0008202); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); lipid biosynthetic process- FDR:0.001783[268](GO:0008610); negative regulation of cell proliferation- FDR:0.001799[356](GO:0008285); positive regulation of apoptotic process- FDR:0.0303738[362](GO:0043065); lipid binding- FDR:0.009252[364](GO:0008289); positive regulation of programmed cell death- FDR:0.03017131[366](GO:0043068); positive regulation of cell death- FDR:0.02163691[388](GO:0010942); signaling receptor activity- FDR:0.001659[405](GO:0038023); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); receptor activity- FDR:3.157e-10[473](GO:0004872); negative regulation of developmental process- FDR:0.02122147[480](GO:0051093)
Frrs1	193	1	oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)	oxidoreductase activity- FDR:1.871e-10[440](GO:0016491)
Rsad2	194	34	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); defense response to other organism- FDR:1.122e-10[108](GO:0098542); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); leukocyte differentiation- FDR:0.004247[163](GO:0002521); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); lymphocyte activation- FDR:0.007719[182](GO:0046649); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); single organism cell adhesion- FDR:0.001707[249](GO:0098602); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); defense response- FDR:2.658e-10[368](GO:0006952); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains- FDR:0.02518674[55](GO:0002822); regulation of adaptive immune response- FDR:0.004944[63](GO:0002819); regulation of leukocyte mediated immunity- FDR:0.01105995[72](GO:0002703); defense response to other organism- FDR:1.122e-10[108](GO:0098542); leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); positive regulation of cytokine production- FDR:1.263e-09[139](GO:0001819); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); positive regulation of immune response- FDR:1.232e-10[154](GO:0050778); leukocyte differentiation- FDR:0.004247[163](GO:0002521); immune effector process- FDR:6.314e-10[167](GO:0002252); innate immune response- FDR:1.329e-10[173](GO:0045087); lymphocyte activation- FDR:0.007719[182](GO:0046649); regulation of immune effector process- FDR:0.01142685[192](GO:0002697); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); response to external biotic stimulus- FDR:1.486e-10[231](GO:0043207); response to other organism- FDR:1.486e-10[231](GO:0051707); regulation of cytokine production- FDR:1.684e-09[232](GO:0001817); response to biotic stimulus- FDR:2.105e-10[246](GO:0009607); single organism cell adhesion- FDR:0.001707[249](GO:0098602); regulation of immune response- FDR:1.263e-10[252](GO:0050776); regulation of defense response- FDR:1.742e-10[271](GO:0031347); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); defense response- FDR:2.658e-10[368](GO:0006952); regulation of protein transport- FDR:0.02148454[392](GO:0051223); regulation of establishment of protein localization- FDR:0.01864413[421](GO:0070201); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Csf1	195	33	regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); inflammatory response- FDR:2.526e-10[151](GO:0006954); leukocyte differentiation- FDR:0.004247[163](GO:0002521); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to cytokine- FDR:1.578e-10[234](GO:0034097); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)	regulation of mononuclear cell proliferation- FDR:0.03255089[96](GO:0032944); regulation of leukocyte proliferation- FDR:0.01759958[97](GO:0070663); cytokine-mediated signaling pathway- FDR:0.0186849[110](GO:0019221); cytokine receptor binding- FDR:0.04749172[121](GO:0005126); regulation of leukocyte differentiation- FDR:0.01119638[122](GO:1902105); positive regulation of response to external stimulus- FDR:0.00353[123](GO:0032103); inflammatory response- FDR:2.526e-10[151](GO:0006954); leukocyte differentiation- FDR:0.004247[163](GO:0002521); innate immune response- FDR:1.329e-10[173](GO:0045087); regulation of hemopoiesis- FDR:0.002993[177](GO:1903706); cellular response to cytokine stimulus- FDR:0.003031[184](GO:0071345); positive regulation of cell adhesion- FDR:0.01769808[184](GO:0045785); positive regulation of cell migration- FDR:0.009741[216](GO:0030335); positive regulation of cell motility- FDR:0.003759[222](GO:2000147); positive regulation of cellular component movement- FDR:0.002331[229](GO:0051272); positive regulation of locomotion- FDR:0.006994[232](GO:0040017); response to cytokine- FDR:1.578e-10[234](GO:0034097); immune response- FDR:2.405e-10[309](GO:0006955); positive regulation of immune system process- FDR:3.608e-10[310](GO:0002684); hemopoiesis- FDR:0.0003673[313](GO:0030097); regulation of cell adhesion- FDR:0.0003608[335](GO:0030155); hematopoietic or lymphoid organ development- FDR:0.0003545[337](GO:0048534); immune system development- FDR:0.0003812[352](GO:0002520); defense response- FDR:2.658e-10[368](GO:0006952); regulation of cell migration- FDR:0.0001943[377](GO:0030334); regulation of response to external stimulus- FDR:1.684e-10[388](GO:0032101); regulation of cell motility- FDR:1.031e-10[398](GO:2000145); regulation of locomotion- FDR:1.531e-10[430](GO:0040012); regulation of cellular component movement- FDR:1.148e-10[438](GO:0051270); positive regulation of cell proliferation- FDR:2.196e-10[439](GO:0008284); protein homodimerization activity- FDR:0.02137525[476](GO:0042803); positive regulation of intracellular signal transduction- FDR:1.075e-10[483](GO:1902533); positive regulation of protein phosphorylation- FDR:1.01e-09[489](GO:0001934)
Naglu	196	2	hydrolase activity, hydrolyzing O-glycosyl compounds- FDR:0.007032[93](GO:0004553); hydrolase activity, acting on glycosyl bonds- FDR:0.006561[108](GO:0016798)	hydrolase activity, hydrolyzing O-glycosyl compounds- FDR:0.007032[93](GO:0004553); hydrolase activity, acting on glycosyl bonds- FDR:0.006561[108](GO:0016798)
Cd151	199	15	leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); lymphocyte activation- FDR:0.007719[182](GO:0046649); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	leukocyte cell-cell adhesion- FDR:0.02504742[129](GO:0007159); homotypic cell-cell adhesion- FDR:0.007023[151](GO:0034109); lymphocyte activation- FDR:0.007719[182](GO:0046649); leukocyte activation- FDR:1.295e-10[227](GO:0045321); single organismal cell-cell adhesion- FDR:0.002362[227](GO:0016337); single organism cell adhesion- FDR:0.001707[249](GO:0098602); focal adhesion- FDR:0.006939[256](GO:0005925); cell-substrate adherens junction- FDR:0.00701[259](GO:0005924); cell-substrate junction- FDR:0.001757[261](GO:0030055); cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell activation- FDR:2.526e-09[276](GO:0001775); adherens junction- FDR:0.00926[294](GO:0005912); anchoring junction- FDR:0.002941[300](GO:0070161); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
Lgals9	200	3	cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)	cell-cell adhesion- FDR:0.001684[273](GO:0098609); cell adhesion- FDR:2.296e-10[489](GO:0007155); biological adhesion- FDR:0.0005137[493](GO:0022610)
